EU network seeks cures for rare muscle diseases

Leading European researchers and clinicians have joined forces in a newly launched Network of Excellence (NoE) on finding new treatments for rare neuromuscular diseases (NMD), such as muscular dystrophies and spinal muscular atrophy.

Dubbed TREAT-NMD (Translational research in Europe - assessment and treatment of neuromuscular), the five-year network is the first of its kind in Europe, bringing together a total of 21 partner organisations from 11 countries. They include charities and companies that will work alongside doctors and researchers in the field.

Neuromuscular diseases (NMD) is a very broad term that encompasses many inherited or acquired diseases and ailments that affect the muscles or their nervous control. It is estimated that come 200,000 people suffer in Europe from these conditions, many of which can result in long-term paralysis or disability. Some forms of NMD can even be deadly, like Spinal Muscular Atrophy (SMA), which is the most common genetic cause of childhood fatality. No cure as yet has been found for SMA.

TREAT-NMD aims to develop best practice in all areas of NMD research and development, in particular by ensuring that the route of a drug candidate from the laboratory bench to an approved medicine is as efficient as possible. To do so, the network is establishing close links with pharmaceutical companies.

The network will also develop a clinical trials coordination centre in Germany, which will provide advice on how to conduct trials, as well as offer training to those participating in the network.

According to Professor Volker Straub, professor for NMDs at Newcastle University and the coordinator of TREAT-NMD, researchers, doctors and patients alike have long awaited the launch of the network. 'This is something that should have been established 10 or 20 years ago, but we were not ready and we did not have the cutting-edge therapies,' Professor Straub told the BBC. He noted that the clinical trials would not have been possible before this network, since they need to be multi-national in order to have sufficient patient numbers.

For further information, please visit:
http://www.ncl.ac.uk/ihg/about/muscle

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...